首页> 外国专利> REGRESSION OF ESTABLISHED ATHEROSCLEROTIC PLAQUES, AND TREATING SUDDEN-ONSET ASTHMA ATTACKS, USING PARP INHIBITORS

REGRESSION OF ESTABLISHED ATHEROSCLEROTIC PLAQUES, AND TREATING SUDDEN-ONSET ASTHMA ATTACKS, USING PARP INHIBITORS

机译:使用PARP抑制剂抑制已建立的动脉粥样硬化斑块并治疗突然发作的哮喘发作

摘要

A method is disclosed for treating and inducing the regression of established atherosclerotic plaques. A method is disclosed fortreating asthma, including treatment of an ongoing asthma attack. In both cases, treatment with PARP inhibitors, such as the PARP inhibitor TIQ-A (Thieno[2,3-c]isoquinolin-5-one), can lead to regression of existing disease and symptoms.
机译:公开了一种用于治疗和诱导已建立的动脉粥样硬化斑块消退的方法。公开了一种治疗哮喘的方法,包括治疗进行中的哮喘发作。在这两种情况下,使用PARP抑制剂(例如PARP抑制剂TIQ-A(硫杂环丁[2,3-c]异喹啉-5-酮))治疗均可导致现有疾病和症状消退。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号